THU-540 Characterization of in vivo mouse models of regressive fibrosis and resolving portal hypertension
Katharina Bonitz(Austrian Academy of Sciences), Thomas Reiberger(ERN GUARD-Heart), Philipp Königshofer(Medical University of Vienna), Stefan Günther Kauschke, Thomas Sorz(Medical University of Vienna), Benedikt Simbrunner(Austrian Academy of Sciences), Vlad Țâru(Iuliu Hațieganu University of Medicine and Pharmacy), Philipp Schwabl(Austrian Academy of Sciences), Hubert Scharnagl(Medical University of Graz), Ines Truebenbach(Boehringer Ingelheim (Germany)), Benedikt Hofer(Austrian Academy of Sciences), Michael Trauner(Medical University of Vienna), Henriette Horstmeier, Peng Sun(Sun Yat-sen University), Oleksander Petrenko, Katharina Regnat(Medical University of Vienna), Kerstin Zinober(Medical University of Vienna), Larissa Pfisterer(Boehringer Ingelheim (Germany))
Cited by 0
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399